Likewise, the expression of chymotrypsin-like protease is increased in the vascular endothelium of women diagnosed with preeclampsia and promotes VE-cadherin disruption and endothelial permeability via its activation of protease-activated receptor 2 (PAR-2) [167,168]. This evidence concerns the gene CDH5 and preeclampsia.